TAGLN2 and pulmonary arterial hypertension: Although the downstream effects of TAGLN2 are primarily suppressed by DNA methylation, our mediation analysis revealed that TAGLN2 itself can promote PAH progression through HLA DR+ monocytes (mediated by 6.15%) and eicosenedioate (mediated by 5.21%).